Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of February 2026
Peter Prince @Peter Prince
Platinum member since January 2017

Location: United States

Gender: Male

Asset investment style: Quantitative technical analysis

Market capitalization:

$8,211,874talents

Virtual portfolio value:

$5,245,270talents

Net overall return per annum:

19.92%

AYA current rank order:

#5

Asset investment philosophy:
Peter Prince trades U.S. stocks with the top #401 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
VATE INNOVATE Corp. Common Stock $0.53 $4.14 76,537 +681.13% $276,299
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 14,872 +2,108.33% $112,878
TEAM Atlassian Corporation Class A Common Stock $28.92 $224.83 201 +677.42% $39,378
SHOP Shopify Inc. Class A Subordinate Voting Shares $56.05 $426.82 104 +661.50% $38,560
AXSM Axsome Therapeutics Inc. Common Stock $4.60 $31.75 1,267 +590.22% $34,399
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 836 +589.24% $34,335
SQ Block Inc. Class A Common Stock $14.50 $99.54 402 +586.48% $34,186
FIVN Five9 Inc. Common Stock $16.31 $110.10 357 +575.05% $33,483
TRNS Transcat Inc. Common Stock $11.35 $73.00 513 +543.17% $31,626
GLOB Globant S.A. Common Shares $34.57 $215.99 168 +524.79% $30,479
Sum $665,623

Top 10 current stock portfolio positions as of February 2026Strategy

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@alin
@Chanel Holden
@Andy Yeh Alpha

Top 20 favorite stocks

#1 - #5 #6 - #10 #11 - #15 #15 - #20
$PSKY $DIS
$WBD $NFLX
$BILI
$IQ
$AAPL

Blog+More

President Trump introduces $50 billion tariffs on Chinese products and new limits on Chinese high-tech investments in America.

Apple Boston

2018-05-25 07:30:00 Friday ET

President Trump introduces $50 billion tariffs on Chinese products and new limits on Chinese high-tech investments in America.

President Trump introduces $50 billion tariffs on Chinese products and new limits on Chinese high-tech investments in America. This new round of tariffs

+See More

President Trump refreshes American fiscal fears and sovereign debt concerns through the One Big Beautiful Bill Act.

Jacob Miramar

2025-06-21 05:25:00 Saturday ET

President Trump refreshes American fiscal fears and sovereign debt concerns through the One Big Beautiful Bill Act.

President Trump refreshes American fiscal fears, worries, and concerns through the One Big Beautiful Bill Act. The Congressional Budget Office (CBO) estimat

+See More

Precautionary-motive and agency reasons for corporate cash management

Monica McNeil

2022-10-05 08:24:00 Wednesday ET

Precautionary-motive and agency reasons for corporate cash management

Precautionary-motive and agency reasons for corporate cash management Bates, Kahle, and Stulz (JF 2009) empirically find that public firms have doubled t

+See More

The financial services industry needs fewer banks worldwide.

Daphne Basel

2022-08-30 10:32:00 Tuesday ET

The financial services industry needs fewer banks worldwide.

The financial services industry needs fewer banks worldwide. As long as banks have existed in human history, their managers have realized how not all dep

+See More

BAC chief investment strategist Michael Hartnett points out that U.S. corporate debt accumulation can cause the next financial crisis.

John Fourier

2018-09-23 08:37:00 Sunday ET

BAC chief investment strategist Michael Hartnett points out that U.S. corporate debt accumulation can cause the next financial crisis.

Bank of America Merrill Lynch's chief investment strategist Michael Hartnett points out that U.S. corporate debt (not household credit supply or bank ca

+See More

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle

John Fourier

2024-05-05 10:31:00 Sunday ET

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its

+See More